FDA grants EUA for Covid-19 test using self-collected saliva samples
The FDA authorisation allows for testing saliva specimens at the RCGL using the molecular LDT Covid-19 test
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 May 20
The FDA authorisation allows for testing saliva specimens at the RCGL using the molecular LDT Covid-19 test
08 May 20
Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is key.…
08 May 20
Bioclinica's COVID-19 Clinical Adjudication Solution is designed to quickly evaluate a clinical trial protocol and charter to determine…
07 May 20
Both BGI Genomics and MGI are working together to offer high throughput, clinically validated solutions to facilitate large-scale…
06 May 20
The new Covid-19 diagnostic assay has been developed using real-time, reverse transcription polymerase chain reaction (rRT-PCR) method
06 May 20
eCaseLink combines Participant Registration, eConsent, eSource, EDC, IRT/IWRS/RTSM, eCOA/ePRO, CTMS and Safety into a single system
06 May 20
Complements SGB’s recent announcement of its strategic drive into medical ‘pop up’ clinics and testing centers using its…
05 May 20
The high sensitivity of SARS-CoV-2 ddPCR test allows screening upper respiratory samples in patients with a low viral…
05 May 20
AVROBIO is developing a near-patient busulfan assay; upon appropriate regulatory clearance, Saladax expects to make the assay commercially…
05 May 20
WatchPAT ONE is a home-based solution for diagnosing respiratory sleep disorders, including sleep apnea